Whether the loss of maspin expression during prostate cancer progression could play a causal role in the switch from anti-tumor to pro-tumor immunity remains to be determined with other prostate tumor cell lines in xenograft models and appropriate genetic mouse model for prostate cancer. Here, SERPINB5 is linked to neoplasm.